INTERNATIONAL PATENT: CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD., 成都倍特药业股份有限公司 FILES APPLICATION FOR "MODIFIED NUCLEOSIDE, DOUBLE-STRANDED RNA MOLECULE COMPRISING SAME AND USE"

GENEVA, Nov. 24 -- CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. (No. 263, Hexiang 3rd Street, High-tech ZoneChengdu, Sichuan 610094), 成都倍特药业股份有限公司 (中国四川省成都市高新区和祥三街263号) filed a patent application (PCT/CN2025/095456) for "MODIFIED NUCLEOSIDE, DOUBLE-STRANDED RNA MOLECULE COMPRISING SAME, AND USE" on May 16, 2025. With publication no. WO/2025/237408, the details related to the patent application was published on Nov 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by t...